# Cleveland Clinic Mercy Hospital IRB – FDA Inspection, Feb 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital-irb/e327bdb5-98fe-4cd9-bb81-17c698978d2b
Source feed: FDA_Inspections

> FDA inspection 1230083 of Cleveland Clinic Mercy Hospital IRB, February 09, 2024. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230083
- Company Name: Cleveland Clinic Mercy Hospital IRB
- Inspection Date: 2024-02-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 926458 - 2015-06-01](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital-irb/3a26d2f6-b649-4f16-92a0-599b69a460f9)
- [FDA Inspection 553743 - 2008-12-15](https://www.keypedia.com/records/fda_inspections/cleveland-clinic-mercy-hospital-irb/b1a46be6-0a3d-437f-8750-31344f605669)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/craig-t-rybus/246aad79-6370-42e2-af6e-c0079c1bcbc6)

Company: https://www.keypedia.com/companies/cleveland-clinic-mercy-hospital-irb/506bdcd2-c31a-4d50-b886-a1c835636149

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c